Publications

December 8, 2022

Presentation: Unlocking the potential of PVRIG & TIGIT pathways to deliver the next transformational cancer immunotherapy drugs

Eran Ophir, SVP Research & Drug Discovery, Compugen, TIGIT Axis Therapies Summit, December 8, 2022

December 8, 2022

Presentation Video: Unlocking the potential of PVRIG & TIGIT pathways to deliver the next transformational cancer immunotherapy drugs

Eran Ophir, SVP Research & Drug Discovery, Compugen, TIGIT Axis Therapies Summit, December 8, 2022

September 30, 2022

Potential of PVRIG and TIGIT blockade in addressing immunotherapy resistance

Eran Ophir, Immuno UK, London, UK, 30 September 2022

June 28, 2022

PVRIG and TIGIT immune checkpoint blockade in cancer: Emerging translational data from clinical trials

Pierre Ferré, AIS 2022 Montpellier, France, 28 June 2022

December 9, 2021

Harnessing PVRIG & TIGIT Combination in Anti-Cancer Immunity

Eran Ophir, VP Research & Drug Discovery, TIGIT Therapies Digital Summit

Scroll to Top